According to previous studies, the possible molecular mechanisms of its anti-obesity effects may involve the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway and neuropeptide Y in the central nervous system [13, 27]. The gene discussed is NPY; the disease is obesity disorder.